[Therapeutic Results of Betahistine on Meniere's Disease. Multi-variable Analysis of the Results of the Double Blind Test and Fisher's Evaluation Method]
Overview
Authors
Affiliations
Systemic pharmacological interventions for Ménière's disease.
Webster K, Galbraith K, Harrington-Benton N, Judd O, Kaski D, Maarsingh O Cochrane Database Syst Rev. 2023; 2:CD015171.
PMID: 36827524 PMC: 9948543. DOI: 10.1002/14651858.CD015171.pub2.
Betahistine for symptoms of vertigo.
Murdin L, Hussain K, Schilder A Cochrane Database Syst Rev. 2016; (6):CD010696.
PMID: 27327415 PMC: 7388750. DOI: 10.1002/14651858.CD010696.pub2.
Meta-analysis of clinical studies with betahistine in Ménière's disease and vestibular vertigo.
Nauta J Eur Arch Otorhinolaryngol. 2013; 271(5):887-97.
PMID: 23778722 DOI: 10.1007/s00405-013-2596-8.
James A, Thorp M BMJ Clin Evid. 2009; 2007.
PMID: 19454061 PMC: 2943800.
Betahistine for Menière's disease or syndrome.
James A, Burton M Cochrane Database Syst Rev. 2001; (1):CD001873.
PMID: 11279734 PMC: 6769057. DOI: 10.1002/14651858.CD001873.